AstraZeneca Reaffirms 2011 Earnings Forecast
AstraZeneca PLC (NYSE: AZN) reaffirmed its full-year earnings forecast guidance for 2011.
It projects core earnings in the lower half of $7.20 to $7.40 per share.
AZN shares gained 0.26% to close at $46.97 on Friday.







